‘I perceive it to be less harmful, I have no idea if it is or not:’ a qualitative exploration of the harm perceptions of IQOS among adult users

Autor: Katherine A. East, Charlotte N. E. Tompkins, Ann McNeill, Sara C. Hitchman

Publikováno v: Harm Reduction Journal, Vol 18, Iss 1, Pp 1-12 (2021)

Abstract Background Harm perceptions of tobacco and nicotine products can influence their use and could be targeted by policies to change behaviour. IQOS was introduced to the UK in 2016, and there is little independent qualitative research on IQOS h

Externí odkaz: https://doaj.org/article/c1230051f2d840168ae7fe71289cc741

‘I perceive it to be less harmful, I have no idea if it is or not:’ a qualitative exploration of the harm perceptions of IQOS among adult users

Autor: Ann McNeill, Katherine A. East, Sara C. Hitchman, Charlotte N. E. Tompkins

Publikováno v: Harm Reduction Journal, Vol 18, Iss 1, Pp 1-12 (2021)
Harm Reduction Journal

Background Harm perceptions of tobacco and nicotine products can influence their use and could be targeted by policies to change behaviour. IQOS was introduced to the UK in 2016, and there is little independent qualitative research on IQOS harm perce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e908a0100083de0f4256ed887a18128b
https://doaj.org/article/c1230051f2d840168ae7fe71289cc741

Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences

Autor: Joanne Neale, John Strang, Charlotte N. E. Tompkins

Publikováno v: Drug and Alcohol Review
Neale, J, Tompkins, C N E & Strang, J S 2019, ' Depot buprenorphine injections for opioid use disorder : Patient information needs and preferences ', Drug and Alcohol Review, vol. 38, no. 5, pp. 510-518 . https://doi.org/10.1111/dar.12939

Introduction and Aims: There has been significant recent investment in new medications for opioid use disorder, including buprenorphine depot injections. Patients and professionals need good quality, independent information on medications to help the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448c7384348e6c1947e19fad495da849
http://europepmc.org/articles/PMC6772117

A qualitative study of the practices and experiences of staff in multidisciplinary child sexual exploitation partnerships in three English coastal towns

Autor: Christine Barter, Charlotte N. E. Tompkins, Alastair Neil Roy, Polly Radcliffe, Matthew Brooks

This article presents findings from a qualitative study of the practices and experiences of people working in multi-disciplinary child sexual exploitation (CSE) partnerships in three coastal towns in England. The study is based on focus groups conduc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::308a36546086c6c69564b54896f7f644

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

Autor: Charlotte N. E. Tompkins, Joanne Neale, John Strang

Publikováno v: Harm Reduction Journal
Harm Reduction Journal, Vol 16, Iss 1, Pp 1-9 (2019)
Neale, J, Tompkins, C N E & Strang, J 2019, ' Prolonged-release opioid agonist therapy : qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations ', Harm Reduction Journal, vol. 16, no. 1, 25 . https://doi.org/10.1186/s12954-019-0296-4

BackgroundOptions for opioid agonist therapy (OAT) are expanding with the development of prolonged-release (also known as extended-release) 1-week, 1-month, and 6-month formulations of buprenorphine. There is an assumption that patients will welcome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb1a829bd23490f571eed5013e1aa24
http://europepmc.org/articles/PMC6446264